KLRK1 and breast carcinoma: Exosomes from T47D breast carcinoma cells decreased the amount of NKG2D-positive lymphocytes within peripheral blood lymphocytes (PBL), which was modulated through NKG2D ligands such as MICB, CD81, and MHC Class I on exosomes [33].